# New Technologies for Blood Glucose Management in Elderly Diabetics: An Interpretation of the Guidelines for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition)

## TL;DR

This paper discusses new technologies for managing blood glucose in elderly diabetics, based on updated Chinese guidelines that emphasize personalized care and modern tools.

## Contribution

The paper interprets the 2024 Chinese guidelines, highlighting new technologies and their clinical implications for elderly diabetes management.

## Key findings

- Stratified, individualized care is recommended for elderly diabetics due to their complex health profiles.
- Technologies like continuous glucose monitoring and smart insulin pens improve glycemic control in this population.
- The guidelines emphasize evidence-based use of modern tools to enhance long-term outcomes.

## Abstract

The burden of diabetes in the elderly is becoming increasingly severe due to the aging population. Elderly patients with diabetes face unique challenges due to multiple comorbidities, atypical symptoms, an increased risk of hypoglycemia, and limited self‐management capabilities. The Guidelines for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition) advocate for a stratified, individualized approach that addresses the heterogeneous pathophysiologic profiles of these patients. Recent technological advances, including continuous glucose monitoring, smart insulin pens, needle‐free injection systems, and new insulin pumps, have significantly improved glycemic management. The updated guidelines systematically review evidence‐based recommendations for managing diabetes in the elderly, emphasizing the benefits of modern monitoring and insulin delivery technologies. This article interprets the updated guidelines with a focus on the technical principles, clinical benefits, and application dilemmas to ultimately improve long‐term outcomes among elderly patients with diabetes.

This article reviews the latest advances in diabetes management technologies, and expound the technical principles, clinical benefits, and application dilemmas for elderly diabetes patients.